EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study

Sisi Luan iD, Jinyan Zhang, Chenglong Wang, Ziqi Wang, Jianbo Zhou

Brain and Behavior · 2025

DOI: 10.1002/brb3.70646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Sisi Luan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Carnitine, Cognition. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Clinical trials investigating the association between acylcarnitines and cognitive function have yielded conflicting results. We conducted a Mendelian randomization (MR) study to examine the causal associations between 20 acylcarnitines and neurocognitive outcomes.

Methods

Single‐nucleotide polymorphisms of 20 acylcarnitines were extracted from primary European ancestry‐based genome‐wide association studies. Two‐sample MR (TSMR) was performed to initially screen for acylcarnitines potentially associated with cognitive performance. Further TSMR analysis was conducted to investigate the associations between specific acylcarnitines and other cognitive outcomes, dementia, and brain structure.

Results

Among the 20 acylcarnitines, we observed that lower genetically predicted levels of butyrylcarnitine ( β = −0.06, 95% CI: [−0.11 to −0.02], p = 0.003) and acetyl‐L‐carnitine ( β = −0.02, 95% CI: [−0.04 to 0], p = 0.04) were associated with adverse neurocognitive effects. Furthermore, we found a negative correlation between low genetically predicted levels of butyrylcarnitine and cognitive function ( β = −0.17, 95% CI: [−0.3 to −0.05], p = 0.01) as well as intelligence ( β = −0.05, 95% CI: [−0.09 to −0.02], p = 0.003). However, there was no evidence supporting any association between these two acylcarnitines and dementia or brain structure.

Conclusions

Our results suggest a causal association between acetyl‐L‐carnitine and butyrylcarnitine levels and adverse neurocognitive effects. Multicenter, multiregional, and large sample studies are needed to further validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnitineCognitionHumansMendelian Randomization AnalysisGenome-Wide Association StudyPolymorphism, Single NucleotideMaleFemaleBrainDementiaMiddle AgedAgedAcetylcarnitine

Stichwörter der Autor:innen

acylcarnitinesbrain structurecognitiondementia

Substanzen

CarnitineacylcarnitineAcetylcarnitine

Autor:innen und Institutionen

  • Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Plastic Surgery Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Sisi Luan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Luan, S., Zhang, J., Wang, C., Wang, Z., & Zhou, J. (2025). The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study. Brain and Behavior. https://doi.org/10.1002/brb3.70646

Vancouver

Luan S, Zhang J, Wang C, Wang Z, Zhou J. The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study. Brain and Behavior. 2025. doi:10.1002/brb3.70646

BibTeX
@article{Luan2025,
  author = {Luan, Sisi and Zhang, Jinyan and Wang, Chenglong and Wang, Ziqi and Zhou, Jianbo},
  title = {The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70646}
}
Kostenlos starten →